BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24895598)

  • 1. Plasmid transfer of plasminogen K1-5 reduces subcutaneous hepatoma growth by affecting inflammatory factors.
    Koch LA; Schmitz V; Strassburg CP; Raskopf E
    Biomed Res Int; 2014; 2014():656527. PubMed ID: 24895598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumoural effects of PlgK1-5 are directly linked to reduced ICAM expression, resulting in hepatoma cell apoptosis.
    Schmitz V; Sauerbruch T; Raskopf E
    Int J Colorectal Dis; 2012 Aug; 27(8):1029-38. PubMed ID: 22451253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen fragment K1-5 improves survival in a murine hepatocellular carcinoma model.
    Schmitz V; Raskopf E; Gonzalez-Carmona MA; Vogt A; Rabe C; Leifeld L; Kornek M; Sauerbruch T; Caselmann WH
    Gut; 2007 Feb; 56(2):271-8. PubMed ID: 16809420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.
    Raskopf E; Vogt A; Sauerbruch T; Schmitz V
    J Hepatol; 2008 Dec; 49(6):977-84. PubMed ID: 18845354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
    Raskopf E; Dzienisowicz C; Hilbert T; Rabe C; Leifeld L; Wernert N; Sauerbruch T; Prieto J; Qian C; Caselmann WH; Schmitz V
    Hepatology; 2005 Jun; 41(6):1233-40. PubMed ID: 15915456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.
    Kornek M; Raskopf E; Tolba R; Becker U; Klöckner M; Sauerbruch T; Schmitz V
    Liver Int; 2008 Apr; 28(4):509-18. PubMed ID: 18339078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth.
    Yang H; Wang J; Fan JH; Zhang YQ; Zhao JX; Dai XJ; Liu Q; Shen YJ; Liu C; Sun WD; Sun Y
    Toxicol Appl Pharmacol; 2017 Jan; 315():90-101. PubMed ID: 27986624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes.
    Guo J; Ma Z; Ma Q; Wu Z; Fan P; Zhou X; Chen L; Zhou S; Goltzman D; Miao D; Wu E
    Curr Med Chem; 2013; 20(33):4131-41. PubMed ID: 23992309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF.
    Zakaria S; Helmy MW; Salahuddin A; Omran G
    Biomed Pharmacother; 2018 Dec; 108():65-75. PubMed ID: 30216802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypoxia-inducible factor-1α silencing on the proliferation of CBRH-7919 hepatoma cells.
    Xu LF; Ni JY; Sun HL; Chen YT; Wu YD
    World J Gastroenterol; 2013 Mar; 19(11):1749-59. PubMed ID: 23555163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
    Li J; Piao YF; Jiang Z; Chen L; Sun HB
    World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells.
    Jing Y; Sun K; Liu W; Sheng D; Zhao S; Gao L; Wei L
    Cancer Lett; 2018 Oct; 434():22-32. PubMed ID: 29981431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal inflammation impairs intestinal microvascular development through a TNF-dependent mechanism and predisposes newborn mice to necrotizing enterocolitis.
    Yan X; Managlia E; Tan XD; De Plaen IG
    Am J Physiol Gastrointest Liver Physiol; 2019 Jul; 317(1):G57-G66. PubMed ID: 31125264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
    Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
    BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
    Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
    Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib combined with dasatinib therapy inhibits cell viability, migration, and angiogenesis synergistically in hepatocellular carcinoma.
    Cheng CC; Chao WT; Shih JH; Lai YS; Hsu YH; Liu YH
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):143-153. PubMed ID: 33860837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K; Koga H; Ueno T; Yoshida T; Maeyama M; Torimura T; Yano H; Kojiro M; Sata M
    Cancer Res; 2006 May; 66(9):4826-34. PubMed ID: 16651438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M; Nakao K; Goto T; Nishimura D; Kawashimo H; Shibata H; Motoyoshi Y; Taura N; Ichikawa T; Hamasaki K; Eguchi K
    J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.